The Ci3+3 Design for Dual-Agent Combination Dose-Finding Clinical Trials

03/25/2021
∙
by   Shijie Yuan, et al.
∙
0
∙

We propose a rule-based statistical design for combination dose-finding trials with two agents. The Ci3+3 design is an extension of the i3+3 design with simple decision rules comparing the observed toxicity rates and equivalence intervals that define the maximum tolerated dose combination. Ci3+3 consists of two stages to allow fast and efficient exploration of the dose-combination space. Statistical inference is restricted to a beta-binomial model for dose evaluation, and the entire design is built upon a set of fixed rules. We show via simulation studies that the Ci3+3 design exhibits similar and comparable operating characteristics to more complex designs utilizing model-based inferences. We believe that the Ci3+3 design may provide an alternative choice to help simplify the design and conduct of combination dose-finding trials in practice.

READ FULL TEXT

Please sign up or login with your details

Continue with:
Or login with email
Enter Password
Re-enter Password

Forgot password? Click here to reset
Success!
Error Icon An error occurred

Sign in with Google

×

Use your Google Account to sign in to DeepAI

×
Pro

Consider DeepAI Pro

Subscribe to DeepAI Pro
DeepAI Pro
Provides a limited generation allowance each month. When exceeded, you are charged overage rates available at deepai.org/pricing. Also includes an ad-free experience and API access. Renews automatically until canceled. Non-refundable.
Subtotal
Total due today

Payment

Add DeepAI credits
DeepAI credits
One-time purchase. Credits are added to your wallet after payment.
Subtotal
Total due today

Payment